Conclusions
AL-CA patients had marked reductions in LASr and LASct. LA strain may be
helpful in differentiating AL-CA from HHD patients.
Reference
1. Ikura H, Endo J, Kitakata H, Moriyama H, Sano M, Fukuda K. Molecular
Mechanism of Pathogenesis and Treatment Strategies for AL Amyloidosis.International journal of molecular sciences. 2022;23(11).
2. Martinez-Naharro A, Baksi AJ, Hawkins PN, Fontana M. Diagnostic
imaging of cardiac amyloidosis. Nature reviews Cardiology.2020;17(7):413-426.
3. Rapezzi C, Merlini G, Quarta CC, et al. Systemic cardiac amyloidoses:
disease profiles and clinical courses of the 3 main types.Circulation. 2009;120(13):1203-1212.
4. Sanchorawala V, Sun F, Quillen K, Sloan JM, Berk JL, Seldin DC.
Long-term outcome of patients with AL amyloidosis treated with high-dose
melphalan and stem cell transplantation: 20-year experience.Blood. 2015;126(20):2345-2347.
5. Quarta CC, Gonzalez-Lopez E, Gilbertson JA, et al. Diagnostic
sensitivity of abdominal fat aspiration in cardiac amyloidosis.European heart journal. 2017;38(24):1905-1908.
6. Falk RH. Diagnosis and management of the cardiac amyloidoses.Circulation. 2005;112(13):2047-2060.
7. Dubrey SW, Hawkins PN, Falk RH. Amyloid diseases of the heart:
assessment, diagnosis, and referral. Heart (British Cardiac
Society). 2011;97(1):75-84.
8. Falk RH, Alexander KM, Liao R, Dorbala S. AL (Light-Chain) Cardiac
Amyloidosis: A Review of Diagnosis and Therapy. Journal of the
American College of Cardiology. 2016;68(12):1323-1341.
9. Rausch K, Scalia GM, Sato K, et al. Left atrial strain imaging
differentiates cardiac amyloidosis and hypertensive heart disease.The international journal of cardiovascular imaging.2021;37(1):81-90.
10. Nochioka K, Quarta CC, Claggett B, et al. Left atrial structure and
function in cardiac amyloidosis. European heart journal
Cardiovascular Imaging. 2017;18(10):1128-1137.
11. Kobayashi Y, Moneghetti KJ, Boralkar K, et al. Challenging the
complementarity of different metrics of left atrial function: insight
from a cardiomyopathy-based study. European heart journal
Cardiovascular Imaging. 2017;18(10):1153-1162.
12. de Gregorio C, Dattilo G, Casale M, Terrizzi A, Donato R, Di Bella
G. Left Atrial Morphology, Size and Function in Patients With
Transthyretin Cardiac Amyloidosis and Primary Hypertrophic
Cardiomyopathy - Comparative Strain Imaging Study. Circulation
journal : official journal of the Japanese Circulation Society.2016;80(8):1830-1837.
13. Brand A, Frumkin D, Hübscher A, et al. Phasic left atrial strain
analysis to discriminate cardiac amyloidosis in patients with unclear
thick heart pathology. European heart journal Cardiovascular
Imaging. 2021;22(6):680-687.
14. Aimo A, Fabiani I, Giannoni A, et al. Multi-chamber speckle tracking
imaging and diagnostic value of left atrial strain in cardiac
amyloidosis. European heart journal Cardiovascular Imaging.2022;24(1):130-141.
15. Tadic M, Cuspidi C, Marwick TH. Phenotyping the hypertensive heart.European heart journal. 2022;43(38):3794-3810.
16. Iio C, Inoue K, Nishimura K, et al. Characteristics of Left Atrial
Deformation Parameters and Their Prognostic Impact in Patients with
Pathological Left Ventricular Hypertrophy: Analysis by Speckle Tracking
Echocardiography. Echocardiography (Mount Kisco, NY).2015;32(12):1821-1830.
17. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac
chamber quantification by echocardiography in adults: an update from the
American Society of Echocardiography and the European Association of
Cardiovascular Imaging. Journal of the American Society of
Echocardiography : official publication of the American Society of
Echocardiography. 2015;28(1):1-39.e14.
18. Kawakami H, Ramkumar S, Nolan M, et al. Left Atrial Mechanical
Dispersion Assessed by Strain Echocardiography as an Independent
Predictor of New-Onset Atrial Fibrillation: A Case-Control Study.Journal of the American Society of Echocardiography : official
publication of the American Society of Echocardiography.2019;32(10):1268-1276.e1263.
19. Marek J, Palecek T, Magne J, et al. Comparison of echocardiographic
parameters in Fabry cardiomyopathy and light-chain cardiac amyloidosis.Echocardiography (Mount Kisco, NY). 2018;35(11):1755-1763.
20. Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the
Evaluation of Left Ventricular Diastolic Function by Echocardiography:
An Update from the American Society of Echocardiography and the European
Association of Cardiovascular Imaging. European heart journal
Cardiovascular Imaging. 2016;17(12):1321-1360.
21. Fan JL, Su B, Zhao X, et al. Correlation of left atrial strain with
left ventricular end-diastolic pressure in patients with normal left
ventricular ejection fraction. The international journal of
cardiovascular imaging. 2020;36(9):1659-1666.
22. Gan GCH, Bhat A, Chen HHL, et al. Determinants of LA reservoir
strain: Independent effects of LA volume and LV global longitudinal
strain. Echocardiography (Mount Kisco, NY).2020;37(12):2018-2028.
23. Pandozi C, Santini M. Update on atrial remodelling owing to rate;
does atrial fibrillation always ’beget’ atrial fibrillation?European heart journal. 2001;22(7):541-553.
24. Hoit BD. Left atrial size and function: role in prognosis.Journal of the American College of Cardiology.2014;63(6):493-505.
25. Cameli M, Mandoli GE, Loiacono F, Sparla S, Iardino E, Mondillo S.
Left atrial strain: A useful index in atrial fibrillation.International journal of cardiology. 2016;220:208-213.
26. Kuppahally SS, Akoum N, Burgon NS, et al. Left atrial strain and
strain rate in patients with paroxysmal and persistent atrial
fibrillation: relationship to left atrial structural remodeling detected
by delayed-enhancement MRI. Circulation Cardiovascular imaging.2010;3(3):231-239.